contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    pageUrl
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
  ... on Webcast {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
      researchContent {
        title
        lang
        pdfUrl
        relatedContent {
          __typename
          ...PublishingDetails
          ...Reactions
          id
        }
        content {
          title
          lang
          slug
          htmlBody
          publishedAt
          createdAt
          changedAt
          isOutdated
          isPremium
        }
      }
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


attanas-immunity-profiles-depicted-in-the-life-science-section-of-yesterdays-dagens-nyheter

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

Attana conducts research and development of pharmaceuticals. The company specializes in biological interaction characterization, which is used for analysis in the development of new drugs. The company's patented solutions are used in the study of binding properties and macrostructures in cells, proteins, viruses and bacteria. Operations are primarily in the Nordic region and Europe. The company was founded in 2002 and is headquartered in Stockholm.

“Tag dine tab hurtigt” er en ret god talemåde, når det gælder denne type selskaber.

Denne multibagger har vist multibagget den forkerte vej, så der kun er 1/20 af værdien tilbage.

En lille portion, der ligger og bliver sur i bunden af porteføljen, og jeg er ikke ligefrem begejstret for at deltage i emissionen. Må indrømme, at jeg slet ikke har fulgt med i firmaets gøren og laden på det seneste.

Der er en emission på vej. Jeg overvejer, om jeg endelig skal realisere tabet på 95 %, eller om jeg stadig skal finansiere det her lækkende skib. Er der andre, der stadig er med ombord?

Börskollen              Kvartalsrapport för perioden 1 januari - 31 mars 2022 i Attana AB    Pressmeddelande i aktien Attana. Kvartalsrapport för perioden 1 januari - 31 mars 2022 i Attana AB.                             Finansielt overblik (ikke revideret af selskabets revisor):  Nettoomsætning DKK 3,1 (1,1) mio. Andre driftsindtægter DKK 0,0 (0,0) mio. Driftsresultat DKK -2,1 (-3,4) mio. Resultat efter finansielle poster DKK -2,1 (-3,5) mio. Resultat efter skat DKK -2,1 (-3,5) mio. Indtjening pr. aktie - DKK 0,0102 (-0,0166)

God pointe, det havde jeg ikke tænkt på.

Kunne IDL Biotech have haft denne kompetence? Det er nu en del af Arocelli.

Attana

In the article Professor Ian Nicholls, Professor Peter Heydebreck and Teodor provides their views of the value of Attana's Immunity Profiles.Read the article online (https://www.dn.se/brandstudio...

<div class="abstract"><p>In the article Professor Ian Nicholls, Professor Peter Heydebreck and Teodor provides their views of the value of Attana's Immunity Profiles.</p></div><p>Read the article online&nbsp;(<a href="https://www.dn.se/brandstudio/attana/nytt-test-visar-ditt-skydd-mot-en-sjukdom/">https://www.dn.se/brandstudio/attana/nytt-test-visar-ditt-skydd-mot-en-sjukdom/</a>) or in the attachment (in Swedish)</p>

Attanas immunity profiles depicted in the Life Science section of yesterday's Dagens Nyheter

Attanas immunity profiles depicted in the Life Science section of yesterday's Dagens Nyheter